Should Soldiers Take Oral Tranexamic Acid Before Going into Battle?


Journal

The journal of trauma and acute care surgery
ISSN: 2163-0763
Titre abrégé: J Trauma Acute Care Surg
Pays: United States
ID NLM: 101570622

Informations de publication

Date de publication:
10 Apr 2024
Historique:
medline: 10 4 2024
pubmed: 10 4 2024
entrez: 10 4 2024
Statut: aheadofprint

Résumé

Tranexamic acid is an inexpensive antifibrinolytic treatment that reduces morbidity and mortality in civilian and military trauma patients. It must be administered within 3 hours of the injury, and its efficacy is greater the earlier it is given. It is already used preventively in the civilian environment in a number of indications to reduce bleeding and bleeding-related mortality. We wondered about the potential benefits of preventive oral administration of tranexamic acid prior to an assault for military personnel with a potential risk of injury.

Identifiants

pubmed: 38595230
doi: 10.1097/TA.0000000000004343
pii: 01586154-990000000-00692
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: JTACS COI Disclosure forms for all authors have been supplied and are provided as supplemental digital content (http://links.lww.com/TA/D720).

Auteurs

Nicolas Cazes (N)

Laveran Army Teaching Hospital, Emergency Department, Marseille, France.

Simon-Pierre Corcostegui (SP)

Paris Fire Brigade, Paris, France.

Steven Lovi (S)

French Military Health System, Paris, France.

Emeric Romary (E)

French Military Health System, Paris, France.

Vincent Desrobert (V)

French Military Health System, Paris, France.

Lionel Lidzborski (L)

French Military Health System, Paris, France.

Clément Derkenne (C)

French Military Health System, Paris, France.

Classifications MeSH